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Abstract 
Background: Colorectal cancer (CRC) is the second leading 
cause of cancer death in the United States and the third most 
commonly diagnosed cancer in men and women. Despite 
published guidelines advocating screening for average-risk adults 
50 years and older, rates of screening remain low. 
Purpose: To investigate whether a patient-directed, computer-
based decision aid about colorectal cancer screening can increase 
patient interest in screening and raise screening rates. 
Study Design: Before-after uncontrolled trial. 
Setting: The University ofNorth Carolina (UN C)-Chapel Hill 
general internal medicine clinic. 
Population: A convenience sample of 80 patients 50-75 years 
old at average risk for CRC who were seen for a new or return 
appointment. 
Methods: Patients viewed the decision aid in which all patients 
viewed a 3-5 minute introduction to CRC screening. They were 
then given a choice to view one to four 3-5 minute segments 
describing individual screening tests or comparative information 
about the tests. Subjects completed before- and after-
questionnaires indicating their intent to ask their provider about 
screening, interest in being screened in the next six months, and 
their readiness to be screened for colorectal cancer. We reviewed 
patient charts 3-6 months afterwards to assess screening test 
ordering and completion. 
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Results: At baseline, the mean intent to ask providers for 
screening was 2.8 as measured on a 4-point Likert scale (1 =not at 
all likely to ask, 4=very likely to ask). After viewing the decision 
aid, mean intent increased to 3.2 (p<O.OOOl, paired t-test). 
Interest in being screened, also measured on a 4-point Likert 
scale (1 =not at all interested, 4=very interested), increased from 
3.2 to 3.5 (p=O.Ol, paired t-test). 89% said the information 
increased their knowledge about colon cancer. After viewing the 
decision aid, 60% were ready to be screened, 18% wanted more 
information but were considering screening, and 22% were not 
ready for testing. Three to six months after viewing the decision 
aid, 46% of participants had a colorectal cancer screening test 
ordered and 39% of patients had completed tests. Among 
patients who were ready to be screened, 51% had tests ordered 
and 43% had completed screening tests. 
Conclusions: In this pilot study, a computer-based colorectal 
cancer decision aid improved patients' interest in being screened 
and subjectively improved patient knowledge about CRC. Only 
approximately half of patients who were ready for screening had 
tests ordered and completed. Future research needs to be done to 
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test if the decision aid in combination with office systems 
support can effectively raise screening rates. 
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I. Burden of Suffering 
Colorectal cancer (CRC) is the second leading cause of cancer 
death and third most diagnosed cancer in the United States. In 
2004, an estimated 152,000 new cases and 57,000 deaths will 
occur due to CRC, accounting for approximately 10% of all new 
cancer cases and deaths nationwide.1• 2 CRC has a high survival 
rate when detected at an early stage but when diagnosed in 
advanced stages, survival is poor. Individuals diagnosed with 
localized disease have a five-year survival rate of 90%, but those 
with distant disease have a five-year survival rate of only 9%.1' 2 
Both CRC incidence and death rates have declined in the past 30 
years. Incidence rates for colorectal cancer began to decline in 
the mid-1980s and stabilized starting in 1995; death rates began 
to decline in the 1970s and continue to decline among men and 
women? Possible reasons for these declines in incidence and 
mortality include an increase in early detection as a result of 
screening as well as improvements in treatments such as adjunct 
chemotherapy. 
Although incidence and mortality rates declined overall 
during the past twenty years, there are important differences by 
sex and race. Death rates from CRC remain approximately 40% 
higher in men compared to women.4 In addition, African-
Americans continue to have the highest age-standardized 
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incidence and death rates compared to other races. From 1996-
2000, the colorectal cancer death rate for black men was 
34.6/100,000 and for white men, 25.3/100,000, with a similar 
absolute difference seen between black and white women.1 
Although overall death rates from CRC declined over the past 
decade at 2.2% per year for white men and 1.8% for white 
women, the declines were 50% less for blacks.4• 5 In addition, 
more African-Americans are diagnosed at an advanced stage6 
and have lower five-year survival rates at every stage of 
t 
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diagnosis1 compared with whites. There are no conclusive 
explanations for these racial disparities but possible reasons 
include poor access to care resulting in delayed diagnoses, lower 
rates of screening, 7 inadequate staging and treatment of disease, 
or a higher burden of co morbid diseases among African-
Americans leading to poorer outcomes. 
II. Colorectal Cancer Screening: Evidence and Guidelines 
There is good evidence that screening for colorectal 
cancer using fecal occult blood testing (FOBT) leads to 
reductions in colorectal cancer incidence and mortality. Mandel 
et al. conducted a trial of 46,551 patients randomized to annual 
FOBT, biennial FOBT, or controls.8 After a follow-up period of 
13 years, they found a 33% reduction in the cumulative mortality 
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rate in the annual FOBT group (5.88/1 000) compared to controls 
(8.83/1 000); this difference was statistically significant. 
Additional data collected after 18 years of follow-up showed a 
persistent 33% mortality rate reduction in the annually screened 
group compared with controls. There was also a statistically 
significant 21% lower mortality rate in the biennial FOBT group 
compared to controls.9 Other large randomized controlled trials 
from Demnark10 and the United Kingdom11 found significant 
18% and 15% reductions in mortality, respectively, with biennial 
FOBT screening. Along with reductions in mortality rates, FOBT 
screening is also associated with reductions in the incidence of 
CRC. In the trial conducted by Mandel et al., cumulative 
incidence ratios for CRC were 0.80 and 0.83 for annual and 
biennial FOBT screening, respectively, after 18 years of 
followup. 12 
There is evidence from case-control studies that screening 
with sigmoidoscopy leads to decreased mortality from colorectal 
cancer. Selby eta!. conducted a case-control study of261 
individuals who died from CRC compared with 868 age- and 
sex-matched controls. 13 They examined the proportions of cases 
and controls who had screening via rigid sigmoidoscopy and 
found an odds ratio for CRC mortality of 0.41 (95% confidence 
interval (CI) 0.25-0.69), adjusted for personal history of CRC or 
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polyps, family history of CRC, numbers of digital rectal exams 
and FOBTs, and number of health visits over the previous 10 L 
years. Another case-control study conducted using data from a 
cohort of 4411 veterans who had died of colon and rectal cancer 
between 1988-1992 showed a mortality benefit to large bowel 
endoscopy, including flexible sigmoidoscopy (FS), rigid 
proctosigmoidoscopy, and colonoscopy. The 4411 patients who 
had died of colorectal cancer were matched by age, sex, and race 
to four living and four dead control patients without colorectal 
cancer. This study found an odds ratio of 0.41 (95% CI, 0.33-
0.50) for any diagnostic procedure of the large bowel.14 There 
are two ongoing large randomized trials of flexible 
sigmoidoscopy, the Prostate, Lung, Colorectal, and Ovarian 
trial15• 16 and the UK Flexible Sigmoidoscopy trial, 17 that will 
provide additional data regarding the mortality benefit of flexible f 
' 
sigmoidoscopy. 
There is one cohort study that showed a mortality benefit 
to the combination ofFOBT and sigmoidoscopy compared to 
sigmoidoscopy alone but the results were of borderline statistical 
significance. Winawer et al. followed a cohort of21,756 patients 
who were non-randomly assigned to an intervention group that 
received annual rigid sigmoidoscopy and FOBT or to a control 
group that received annual sigmoidoscopy alone.18 They found 
that the CRC mortality rate in the intervention group was 
0.3611000 per year vs. 0.63/1000 per year in controls (p=0.053, 
one-tailed test). In addition, patient compliance to FOBT was 
poor. Given the borderline significance of these results, it is 
uncertain whether there is a true mortality benefit to annual 
FOBT and sigmoidoscopy vs. sigmoidoscopy alone. 
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There is no evidence from randomized controlled trials to 
support a mortality benefit for colonoscopy. There is evidence 
that colonoscopy and colon polypectomy can lead to a decrease 
in CRC incidence. The National Polyp Study was comprised of a 
cohort of 1,418 patients who had a complete colonoscopy with 
removal of one or more colon or rectal adenomas. The average 
follow-up time was 5.9 years.19 This cohort was compared to 
three reference groups, two cohorts who had not undergone 
colon polypectomy and one cohort representative of people at 
average risk in the general population. They found statistically 
significant decreases in cumulative incidence in the colon 
polypectomy group when compared to each of the reference 
groups. The observed CRC incidence in the intervention cohort 
was 0.6/1000 person-years compared to 5.8, 5.2, and 2.511000 
person years, respectively, in the reference groups. A 
retrospective cohort study of 1693 colon polypectomy patients 
conducted in Italy also found decreased CRC incidence when 
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compared to the Italian general population?0 Over a mean 
follow-up of 10.5 years there were 6 CRC cases compared to 
17.7 cases expected in the reference population, with an 
incidence ratio of 0.34 (95% CI 0.23, 0.63) comparing observed 
vs. expected incidence. 
In addition to decreasing CRC incidence, co1onoscopy 
may be able to detect advanced colonic neoplasms that would not 
otherwise be detected via sigmoidoscopy. In a cohort of3,121 
veterans who undetwentcolonoscopy;··r(r5% had adenomas 
> 1 Omm in diameter, villous adenomas, high-grade dysplasia, or 
invasive cancer. Of 128 patients with advanced proximal 
neoplasia, 52% did not have distal adenomas. These results 
suggest that colonoscopy may be able to detect pre-malignant 
adenomas that would not be seen by sigmoidoscopy, but to date 
there are no randomized controlled trials to support this assertion 
or to show a mortality benefit to colonoscopy. 
In 2002-2003, the American Gastroenterological 
Association along with a multi-disciplinary consortium panel, the 
U.S. Preventive Services Task Force (USPSTF), and the 
American Cancer Society published guidelines for the screening 
of average-risk adults 50 years and older.21-23 Average-risk is 
defined as individuals without a family or personal history of 
CRC, no personal history of adenomatous polyps, and the 
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absence of an illness such as inflammatory bowel disease that 
predisposes individuals to CRC. Screening modalities endorsed 
by all three organizations include: 1) FOBT yearly; 2) flexible 
sigmoidoscopy (FS) every 5 years; 3) FOBT yearly combined 
with FS every 5 years; 4) double contrast barium enema every 5 
years; and 5) colonoscopy every 10 years (Table 1 ). The 
organizations agree that any one of these methods is an 
appropriate means of screening but that there is no clear evidence 
that any one method is superior. They recommend that providers 
discuss these options with patients and decide on a strategy based 
on patient preferences for screening. 
Colorectal cancer screening also appears to be cost 
effective. In 2002, Pignone et a!. performed a systematic review 
of cost effectiveness analyses of CRC screening. They reviewed 
seven studies and found cost-effectiveness ratios of $10-25,000 
per life-year saved when compared with no screening.24 No 
single screening modality was found to be superior in terms of 
cost-effectiveness. There was insufficient evidence to determine 
an appropriate age to stop screening for CRC. 
III. Colorectal Cancer Screening Rates 
Despite the evidence supporting screening and the 
existence of published guidelines advocating screening, data 
13 
from state and national surveys show that the self-reported rates 
of colorectal cancer screening in the U.S. population are low. L 
The percentage of individuals 50 and over who reported ever 
having a screening test for colorectal cancer ranges from 25% 25 
to 48%26. Although current rates remain low, there has been a 
trend towards increased screening in the past decade. In the 
National Health Interview Survey (NHIS), an annual household 
survey of 49,000 households, there was a trend toward increased 
FOBT use; from 1987-1998, FOBT use in the past three years 
increased from 18% to 29% in men and from 21% to 26% in 
women.25 Rates of sigmoidoscopy in the NHIS were low, 
although there was a trend towards increased use in both men 
and women. The Behavioral Risk Factor Surveillance System 
(BRFSS) survey also found recent increases in CRC screening. 
The BRFSS consists of self-report data collected from a state-
based, random digit-dialed telephone survey administered yearly. 
From 1997-2001, the percentage of individuals reporting FOBT 
within the past 12 months rose from 19.4% in 1997 to 23.5% in 
200 I. Self-reported endoscopy rates with in the past 5 years rose 
from 29.9% to 38.7% over the same time period.27•28 Reasons for 
the differences in screening rates and test use estimates between 
the NHIS and BRFSS are unclear. One possible explanation is 
that the surveys, one national and one state-based, use different 
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survey methods resulting in the sampling of different 
populations. 
There are limitations to these survey findings. One 
limitation is that these are self-reported data that do not 
differentiate between screening vs. diagnostic procedures, 
resulting in an overestimation of screening rates. Another 
limitation is that the surveys do not accurately measure 
compliance with current screening guidelines. The BRFSS 
cannot distinguish between sigmoidoscopy within the past 5 
years and colonoscopy in the past 10 years, and the NHIS only 
reports data on sigmoidoscopy use within the past 3 years. There 
is also potential respondent bias given that response rates range 
from 51.1% in the 2001 BRFSS28 to 74% in the 1998 NHIS25 • 
Despite these limitations, these national surveys show 
that colorectal cancer screening rates less than half of adults over 
50 reporting having been screened for CRC. These rates are far 
below those of mammography and pap smear testing25• 29• 30 and 
fall short of the goals set by Healthy People 2010 which are to 
increase the proportion of adults receiving FOBT in the past 2 
years to 50% and the proportion of adults ever having received a 
sigmoidoscopy to 50%.31 Reasons for the low rates of screening 
include patient, provider, and systems-related factors. 
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IV. Barriers to Screening 
1. Patient-related Factors 
Patient non-adherence to colorectal cancer screening is 
caused by patients' perceptions that screening tests are 
inconvenient, patient misconceptions about screening tests, 
insurance and access issues, and poor patient-provider 
communication. A 1997 review of the literature on patient 
participation in colorectal screening32 found that reasons given 
by patients for nonparticipation included: 1) practical reasons, 
such as time conflicts, inconvenience, lack of interest, being too 
busy, and cost; 2) perceived lack of current health problems or I symptoms of colorectal cancer; 3) anxiety or embarrassment 
about undergoing screening; and 4) not wanting to know about 
health problems or being anxious about test results. Practical 
reasons and perceived lack of health problems or symptoms were 
the most common reasons why patients did not complete 
screening tests such as FOBT and sigmoidoscopy. 
Other patient-related barriers to screening are lack of 
insurance and poor access to health care. An analysis of 1999 
BRFSS data found that underutilization of CRC screening tests 
was most common in those with lower education, a lack of health 
insurance, and low use of preventive services.33 A retrospective 
analysis of a cohort of adults in an academic primary care 
L 
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practice in San Francisco from 1995-1997 found that having 
private insurance was a significant predictor ofFOBT screening 
compared with no insurance, and managed care insurance was a 
predictor of receiving sigmoidoscopy or any type of colon cancer 
screening?4 Lack of insurance coverage has become less of a 
barrier in recent years due to Medicare's addition of colonoscopy 
to its list of covered services in 2001 ?5 For individuals not yet 
eligible for Medicare, lack of insurance is still a barrier to 
screening. 'i--
Access to health care is another barrier that affects those 
t 
in medically underserved areas and can prevent individuals from 
obtaining screening. A focus-group based analysis of21 rural 
Medicaid patients' views on colorectal screening found that a 
main theme was patients' perception of poor access to quality 
healthcare. 36 These patients defined poor quality care as either 
not being offered screening or not having followup of test results. 
In this case, patients had access to a health care system but felt 
that the low quality of care interfered with their ability to comply 
with screening recommendations. 
There is evidence that major barriers to CRC screening are L 
poor patient understanding about CRC and the failure of health 
care providers to recommend screening. Beeker et a!. conducted 
14 focus groups among insured adults 50 and older in Georgia, 
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Kansas, and Pennsylvania. 37 They found that participants were 
poorly informed about colorectal cancer, including the causes 
and risk factors for CRC, and that few were aware of the benefits 
of screening. Many reported that they received little or no 
information about screening from tbeir health care provider and 
identified this lack of counseling as a barrier to screening. 
Similarly, Weizman eta!. conducted focus groups with 39 
individuals in Massachusetts and found that tbere was a low level 
of knowledge about tbe prevalence and risk factors for CRC as 
well as a lack of information given by providers regarding 
screening?8 A study of397 African-Americans enrolled in a 
' i church-based health program found that tbe most common 
perceived barrier was that a health care provider had not 
recommended screening.39 Provider recommendation was also 
important in a study oflow-income African American women; 
physician recommendation was significantly associated with 
adherence to screening.40 A survey of70 patients enrolled in a 
CRC screening program in Alabama found that tbe most 
common reason for nonparticipation was being unaware that 
. d 41 screenmg was ue. 
Although many of these studies consisted of small volunteer 
samples from defined geographic regions, tbey provide insight 
into patient-related barriers to screening. These studies show tbat 
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many patients have misconceptions about colorectal cancer, 
including risk factors and knowledge about the disease, and that 
lack of provider counseling about screening is a significant 
barrier. These results point to the need for increased patient 
education about CRC and screening and the need for improved 
patient-provider communication about screening. 
2. Provider-related factors 
Other barriers to CRC screening are due to provider-
related factors. Reasons that providers fail to counsel or order 
CRC screening tests include lack of time, lack of knowledge 
about current guidelines, concerns about screening effectiveness, 
provider forgetfulness, and rnisperceptions about patient 
preferences. As discussed previously, studies show that patients 
identify the lack of provider counseling as a barrier to screening. 
There is a need to address provider-level barriers to screening in 
order to identifY areas for change and to increase screening rates. 
One barrier to screening is providers' lack of time to 
counsel patients about screening. Patients and providers should 
discuss CRC screening together because of the range of test 
options available and the importance of incorporating patient 
preferences to ensure compliance. This process of shared 
decision making can be time-consuming and, with the time 
19 
constraints of primary care practice, conversations about 
screening are often brief or do not occur. One study by Yarnall et 
a!. calculated a model of the time needed to provide all the 
preventive services recommended by the USPSTF. According to 
their calculations, a family physician would need 7.4 hours a day 
to counsel and provide clinical preventive services in a 2500 
patient panel.42 Ellerbeck eta!. observed 38 rural primary care 
physicians' counseling practices over an 8-week period. They 
found that only 14% of patients 50 and older were counseled 
about CRC screening.43 Although the period of observation was 
only 8 weeks and did not account for prior history of screening, 
half the patients surveyed after the clinical encounter said they 
had not discussed FOBT within the past year or sigmoidoscopy 
within the past 5 years, suggesting that screening was overdue in 
these patients. 
Another provider-level barrier to screening is lack of 
knowledge about existing guidelines and doubts about the 
effectiveness of screening tests. Guidelines for CRC screening 
were not uniform until all major organizations made recent 
revisions in 2002-2003 that advocated any of the five methods of 
L 
screening discussed above. Despite existing guidelines, not all 
providers are knowledgeable about current recommendations and 
may have concerns about test effectiveness. Schroy et a!. 
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surveyed Massachusetts internists and found that 80% were 
aware of at least one of the available published guidelines for 
screening but that physicians' perceived lack of efficacy data was 
associated with lower rates of offering sigrnoidoscopy.44 
Klabunde et a!. administered a national survey to primary care 
providers in 1999 to assess their knowledge about guidelines and 
their perceptions about test effectiveness.45 There was variable 
knowledge about existing guidelines among the 1235 physician 
respondents. Forty-nine percent reported that current ACS 
guidelines were very influential on their screening practices, but 
24% were unfamiliar with USPSTF guidelines and 37% were 
unaware of the GI Consortium guidelines. In terms of screening 
practices, there were discrepancies between guidelines and actual 
practice. Although more than 98% recommended some form of 
CRC screening, 43% started screening average-risk individuals 
at age 40, more than half of general practioners recommended 
sigmoidoscopy every 1-3 years, and 64% ofOB-GYNs said they 
used office-based FOBT and digital rectal exams exclusively for 
CRC screening. More than 80% of respondents rated 
colonoscopy as "very effective" and rated the other screening 
modalities lower in effectiveness. These results show that most 
providers recommend screening but there are variable levels of 
21 
provider knowledge about starting ages, recommended timing of 
screening tests, and efficacy data. 
Another barrier to CRC screening is that providers may 
have incorrect perceptions about patients' acceptance of 
screening. Ling et a!. conducted a cross-sectional survey of 217 
patients and 39 physicians at an academic general medicine 
clinic in order to assess patient and physician preferences for 
CRC screening as well as physicians' perceptions of patient 
preferences.46 They found significant differences in physician 
opinions about patient preferences compared to actual patient 
preferences; 64% of physicians felt that patients considered 
discomfort to be the most important feature when selecting a 
screening method, whereas only 15% of patients actually rated 
discomfort as most important. Likewise, 15% of physicians felt 
that patients thought that accuracy was the most important test 
r 
' 
feature when 54% of patients actually rated this most important. 
These discrepancies show that physicians in this study had 
incorrect opinions of patient preferences about screening, rating 
discomfort as most important to patients while most patients 
chose accuracy as most important. L 
Other surveys also show that providers perceive the most 
common concern for patients to be discomfort. A survey of 77 
primary care providers in Massachusetts found that physicians 
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perceived the most common patient barriers to be discomfort and 
patients' assumptions that they will have symptoms if there is a 
problem.47 Schroy et al.'s survey ofMassachusetts internists 
found that these physicians rated patient fear and anxiety as the 
most common barrier to sigmoidoscopy.44 
Provider views on patient preferences can influence their 
screening recommendations to patients. If providers have 
incorrect perceptions about patients' preferences, they may offer 
or order screening tests that are not compatible with patients' 
actual preferences, possibly leading to lower rates of patient 
compliance. 
3. Office systems-related factors 
The time pressures on primary care providers likely 
contribute to the low rates of CRC screening. There is a need for 
office systems support given the competing demands of acute 
problems, management of chronic diseases, and the need for 
counseling regarding other preventive services. Support in the 
form of performance audits, chart reminder systems, patient 
reminders, and screening test tracking systems are potential 
means of improving the performance of screening. 48 L f 
' Computerized or web-based systems that link patient data to 
patient- and provider-reminders are promising innovations that 
can help expedite and coordinate preventive care in a primary 
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care office setting.49-51 Shea et al. conducted a meta-analysis of 
randomized trials of computer-based clinical reminder systems 
and found that computerized reminders improved the odds of 
colorectal screening compared to control groups who did not 
receive reminders. 50 
Standing orders that can be initiated by a nurse based on 
patient preferences are another means of improving screening 
test ordering rates. Standing orders systems are recommended for 
preventive services such as pneumococcal vaccination52 and have 
been effective in raising pneumococcal vaccination rates in an 
outpatient setting. 53 In a standing orders protocol for CRC 
screening, nurses or other designated staff would be able to order 
screening tests for average-risk patients based on patient 
preferences for screening and a written protocol approved by the 
providers in the practice. Providers would be notified about the 
order and would have the ability to cancel or change the request 
if needed. The implementation of an office-systems 
infrastructure to support CRC screening has the potential to help 
address patient and provider barriers and improve screening 
rates. 
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V. Development and initial testing of a computer-based 
patient decision aid for colorectal cancer screening 
1. Background: Colorectal cancer screening decision aids 
Colorectal cancer screening is a complex issue given the 
many available options for screening and the different risks and 
benefits of each option. Optimally, colorectal cancer screening 
should involve both the patient and provider in a shared decision-
making process where risks, benefits, and patient preferences are 
considered. Time limitations and lack of knowledge about 
current guidelines may prevent providers from adequately 
discussing screening with patients. This may lead to patients 
lacking the knowledge needed to make an informed decision 
about screening. 
To address patients' need for education about screening, 
tools such as decision aids have been developed. Decision aids 
provide information that helps patients understand their options 
for screening as well as the risks and benefits of these options. 54 
Formats include printed brochures, scripts read aloud to patients, 
videotapes, or interactive CD-ROMs. A systematic review found 
that patient decision aids improved knowledge, reduced 
decisional conflict, and helped patients become more active in 
the decision-making process. 54 
t 
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A few decision aids for colorectal cancer have been 
developed and studied. Meade et al. conducted a randomized 
controlled trial of a print booklet and a videotape about 
colorectal cancer screening. 55 They randomized 1100 patients 
from a primary care clinic in Milwaukee to a booklet, videotape, 
or no intervention. Both the booklet and the videotape 
significantly improved scores on a test of colorectal screening 
knowledge by 23% and 26%, respectively, compared to a 3% 
improvement in knowledge among controls. Another CRC 
decision aid developed by Dolan et al. consisted of a short verbal 
description of colorectal cancer and screening tests. 56 In a 
randomized trial of 96 patients enrolled in general medicine 
practices, patients who received the decision aid had a significant 
decrease in decisional conflict due to increased knowledge, better 
clarity of values, and higher ratings of the quality of decisions 
they made vs. controls. There was no difference, however, in the 
rate of screening test completion between the two groups (52% 
of control group and 49% of intervention group). 
These decision aids increased patient knowledge about 
CRC screening but did not increase actual screening rates. We 
conducted a randomized, controlled trial of a patient-directed, 
videotape-based decision aid for colorectal cancer along with a 
, 
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targeted brochure and chart marker that improved patient interest 
in screening and increased rates of test ordering and completion. 
2. Previous Research 
We previously conducted a randomized controlled trial of 
an 11-minute videotape decision aid that contained information 
about susceptibility to colon cancer and descriptive information 
about screening tests. 57 In 1998 we enrolled 249 patients from 
three community primary care practices in North Carolina and 
randomized them to an intervention videotape about colon cancer 
screening or a control videotape about automobile safety. The 
intervention videotape reviewed how screening tests were 
performed, the meaning of positive and negative results, and 
included vignettes in which patients described their experiences 
with screening. It only contained information on flexible 
sigmoidoscopy and FOBT, the two recommended screening 
modalities at the time. After viewing the videotape, patients in 
the intervention group chose a color-coded brochure that 
indicated their stage of readiness to be screened. The color-coded 
brochures were based on Prochaska et al. 's transtheoretical 
model and stages of change. 58 Green indicated that the patient 
was currently ready to be screened, yellow that the patient was 
interested in screening but needed more information, and red that 
27 
they did not want screening. In addition to choosing a color-
coded brochure, a chart marker of the same color chosen by the 
patient was attached to their charts. A research assistant reviewed 
medical records 3-6 months after patients viewed the decision aid 
to assess screening test ordering and completion. 
There was a significant increase in test ordering and 
completion in the intervention group compared to controls and 
there was also an increase in patients' intent to ask providers for 
screening after viewing the intervention videotape. The 
participants' mean age was 63, 59% were female, 84% were 
white, and 73% were high school graduates. 3-6 months after the I viewing the decision aid, test ordering was 21 percentage points 
higher in the intervention groups vs. controls ( 4 7% vs. 26%, 95% 
CI of the difference 9-33). Screening test completion was 14 
percentage points higher (37% in the intervention group vs. 23% 
in controls, 95% CI of the difference 3-25). Among patients 
viewing the intervention video, the mean intent to ask providers 
for screening as measured on a 4-point Likert scale (1 =very 
unlikely to ask, 4=very likely to ask) increased from 2.2 prior to 
viewing the decision aid to 3.1 afterwards (p<0.001). The 
videotape decision aid in combination with a stage-targeted 
brochure and chart marker improved patient intent to be screened 
and increased screening rates in this primary care population. 
L 
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Despite the videotape-based decision aid's success in 
raising screening rates, there were limitations to the format and 
content of the aid that necessitated changes. Because the decision 
aid was produced in videotape form only, it could not be easily 
updated to include information on new screening guidelines that 
now include colonoscopy and barium enema. In addition, the 
videotape could not be tailored to meet different levels of 
knowledge about CRC screening; all patients in the intervention 
group watched the same videotape. In light of these limitations, a 
revised, computer-based form of the decision aid was developed. 
Recent advances in web-based and CD-ROM technology since 
the development of the videotape decision aid made it possible to 
produce a revised version that can be updated to include new 
information and can be tailored to patients' individual knowledge 
needs. 
3. Computer-based decision aid development 
We based the educational content of the computer-based 
decision aid on the content used in the videotape version. 
Additional segments on colonoscopy, barium enema, and 
comparative information about the tests were added. The 
decision aid was programmed into a web-based format that 
directs patients toward an introductory overview of colorectal 
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cancer screening and then gives patients a choice to view one or 
more segments on individual screening tests or a segment 
comparing the tests. Questionnaires were programmed into the 
web-based version to be completed by patients before and after 
viewing the decision aid. 
We conducted two rounds of usability testing with 12 
representative patients per group. Based on feedback from these 
sessions, we increased font sizes and more clearly labeled 
controls to facilitate use of the decision aid. After these changes, 
patients with varying levels of computer experience were able to 
successfully navigate through the choices presented. 
Purpose of the current study 
The goals of this study are to test whether a computer-
based, patient-directed decision aid can increase patient interest 
and knowledge about screening and improve the ordering and 
completion of colorectal cancer screening tests. 
4. Methods 
Study Design 
We enrolled a convenience sample of 80 patients from the 
University of North Carolina (UN C)-Chapel Hill general internal 
medicine clinic from June 2003 through April 2004. Population 
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The participants were adults 50 to 75 years old who were 
currently enrolled in the general internal medicine clinic and 
presented to their provider for a scheduled appointment. 
Eligibility 
Eligibility criteria were: I) the absence of a personal or family 
history of colon cancer in a first degree relative; 2) sufficient 
general health to undergo screening as determined by the 
research assistant (RA) or the primary care provider; and 3) the 
ability to communicate in English. We attempted to enroll 
patients who were not up to date with screening, defined as those 
who did not have FOBT performed within the past year, flexible 
sigmoidoscopy or barium enema within the past 5 years, or 
colonoscopy within the past I 0 years. If it was found after 
patients were enrolled, however, that they were up to date with 
screening, they were allowed to continue in the study. 
Enrollment 
The RA identified eligible patients from a daily review of clinic 
rosters. The medical records of patients ages 50-7 5 were 
reviewed to determine if these patients were up to date with 
screening. Providers were given a general overview of the study, 
and the RA asked providers for permission to approach eligible 
patients prior to each clinic session. In addition to RA 
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recruitment, providers also referred eligible patients for 
participation in tbe study. Eligible patients who presented to the 
clinic were consecutively approached either before or after their 
scheduled appointment and asked to enroll. If tbe patient agreed 
to participate in the study, the RA explained tbe study's purpose, 
described tbe decision aid and the estimated time needed to 
complete the study, and obtained written informed consent. 
Intervention 
The decision aid consisted of an introduction and five additional 
segments tbat described individual screening tests. A physician 
provided narration for all segments. All patients viewed tbe 
introduction tbat described the importance of colorectal cancer 
screening, the benefits of early detection of neoplasms, and gave 
a brief overview of the five available screening options. After 
viewing the introduction, patients were directed to a menu of 
choices tbat allowed them to choose segments on FOBT, flexible 
sigmoidoscopy, colonoscopy, barium enema, or comparative 
information about the tests. Each segment was approximately 3-5 
minutes long and described each screening test, preparation for 
the test, how tbe test is performed and its risks and benefits. All 
segments included multiple vignettes in which patients talked 
about their experiences with CRC screening. 
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Once written informed consent was obtained, participants 
viewed the decision aid on a computer in a private area in the 
clinic. TheRA provided computer assistance as necessary. 
Patients also completed on-line questionnaires before and after 
viewing the decision aid (Appendix A). The questionnaire 
administered before viewing the decision aid asked about 
patients' interest in being screened for CRC in the next 6 months, 
intent to ask their physician about screening, interest in shared 
decision-making, history and type of previous CRC screening, 
and demographic information. After viewing the decision aid, 
participants completed a questionnaire that again asked about 
interest in screening and intent to ask their physician about 
screening. They were also asked if they had gained knowledge 
from using the decision aid, usefulness of the aid in deciding 
whether to be screened, and stage of readiness to be screened. 
Participants indicated their stage of readiness by choosing one of 
three color-coded stages: green indicated that they were ready to 
be screened, yellow that they needed more information, and red 
that they did not want screening. Patients then completed an 
additional questionnaire based on their stage of readiness that 
asked about their preferences for screening tests or the reasons 
why they did not want to be screened. 
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Outcome measures 
Patient-centered outcome measures were: change in 
interest in CRC screening before and after viewing the decision 
aid, usefulness of the information presented, and change in 
knowledge about CRC screening. Intent to ask providers for 
screening was measured on a 4-point Likert scale (1 ==not at all 
likely to ask, 4=very likely to ask). Patients' interest in being 
screened for CRC in the next 6 months was also measured on a 
4-point Likert scale (1 ==not at all interested, 4=definitely 
interested). The mean Likert scores before the decision aid were 
compared to the mean scores after viewing the decision aid. 
Change in knowledge about screening was based on patients' 
self-assessment of whether their knowledge had increased after 
viewing the aid. 
The primary outcome measure was the proportion of 
CRC screening tests ordered and completed. Three to six months 
after patient completion of the decision aid, the RA conducted a 
chart review to determine if CRC screening tests were ordered 
and completed. Test ordering was defined as an FOBT order 
recorded in the clinic's computer database or a colonoscopy or 
sigmoidoscopy order entered into the patient's computerized 
medical record. Test completion was defined as the record of a 
completed FOBT test in the computer database or the report of a 
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completed colonoscopy or sigmoidoscopy in the medical record. 
The FOBT clinic database is a Microsoft Access-based system 
that tracks FOBT ordering and completion. Whenever an FOBT 
is ordered, nurses enter the patients' name, medical record 
number, and date of test ordering into the database. Although this 
system has not been formally evaluated, all patients who had an 
FOBT ordered by a provider should be entered in the clinic 
database at the time of test ordering. Patients who are not listed 
in the database did not have FOBT tests ordered. The patients are 
sent follow-up letters if they fail to return the FOBT cards to 
clinic, and all returned FOBT results are recorded in the 
database. 
Statistical Analysis 
We initially examined the characteristics of the sample by using 
univariate analysis to determine the distribution of each variable. 
The mean, range, and standard distribution were calculated for 
continuous variables and frequencies and percentages were 
tabulated for categorical variables. We used paired t-tests to 
compare the difference in continuous Likert scores before and 
after viewing the decision aid. Frequencies and percentages were 
tabulated for categorical variables in the questionnaires, test 
ordering, and test completion. Pearson's chi-square test was used 
to compare the percentage ordering and completing tests by stage 
35 
of readiness to be screened. A two-sided p-value <0.05 was 
considered statistically significant. Stata version 8.2 (College 
Station, TX) was used for all analyses. Prior approval for the 
study was obtained from the UNC Institutional Review board. 
5. Results 
Demographic characteristics of the 80 patients are shown 
in Table 2. The mean age was 60 years. Fifty-nine percent were 
male and 29% were African American. 81% had health 
insurance; of those with insurance, 18% had Medicare and 46% 
had private insurance. Approximately half of participants had 
previously been screened for colon cancer and 19% were up to 
date with screening. When asked about how they had been 
screened, 48% reported having FOBT, 21% sigmoidoscopy, 19% 
colonoscopy, and 10% barium enema. Almost two-thirds of 
patients said that a provider had discussed CRC screening with 
them in the past. 
Intent to ask providers about screening and interest in 
screening both rose significantly after viewing the decision aid, 
and most patients said that their knowledge about screening 
increased and they found the information useful. Patients' intent 
to ask for screening increased from a mean score of2.8 before 
viewing the decision aid to 3.2 afterwards (p<O.OOOl, paired t-
L 
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test, Figure 1). There was also an increase in patients' interest in 
being screened in the 6 months after viewing the decision aid. 
Prior to viewing the aid, the mean score for interest in being 
screened at was 3.2; this increased to 3.5 (difference, 0.3; 
p=O.Ol, paired t-test). Eighty-nine percent said that the 
information presented increased their knowledge about colon 
cancer, 78% said that the information presented helped them 
decide whether to be screened, and 90% felt that the amount of 
information in the decision aid was just right. Ninety percent 
preferred to make decisions together with their physician. The 
mean amount of time spent viewing the decision aid was 19 
minutes. 
Table 3 shows the percentage of participants who had 
screening tests ordered and completed as determined by chart 
review and a search of the clinic FOBT database 3-6 months 
after completing the decision aid. 16 of the 80 patients were not 
entered into the computer FOBT database and thus did not have 
an FOBT ordered. For test ordering, 46% (37 /80) of patients had 
either an FOBT or endoscopy ordered 3-6 months after viewing 
the decision aid. Twenty-five percent (20/80) had an FOBT 
ordered and 25% had an order for endoscopy. Three patients had 
orders for both FOBT and endoscopy. For test completion, 39% 
(31/80) participants completed either FOBT or endoscopy. 16% 
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(14/80) of patients completed FOBT and 24% (19/80) had 
completed endoscopies. 
Most patients reported that they were ready to be 
screened for CRC. When asked about stage of readiness to be 
screened, 60% chose green, indicating that were ready to be 
tested, 18% chose yellow (needed more information) and 22% 
chose red (not ready to be screened). We did an analysis to 
determine whether those who were ready to be screened were 
' 
more likely to have tests ordered and completed than patients f L 
who were not ready or needed more information. There was a 
greater percentage of test ordering and completion among 
patients choosing green compared to those choosing yellow or 
red but these differences did not reach statistical significance 
(Table 4). Of the 47 patients who chose green, 51% had a test 
ordered after 3-6 months compared to 40% of those choosing 
yellow and 39% of those who chose red (p=0.59). In terms oftest 
completion, 43% of patients who chose green completed a 
screening test compared to 33% of those choosing yellow and 
33% of those choosing red (p=0.71). We conducted another 
analysis after excluding patients who were up to date with L 
screening because these patients might be less likely to have tests 
ordered or completed after viewing the decision aid. There was 
no significant change in the percentage of patients having tests 
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ordered and completed by stage of readiness after excluding 
these patients. 
Among the 47 patients who were ready to be screened, 
diagnostic accuracy was the most important criteria for a 
screening test, and the most preferred test was colonoscopy. 
Fifty-five percent of patients choosing green said that the ability 
of tests to find cancers or polyps was the most important criteria 
in selecting a screening test. The next most important criteria 
were the preparation required for the test (16%) and medications 
needed (11 %). Forty-two percent preferred colonoscopy, with the 
next most preferred tests being FOBT alone (20%) and FOBT in 
combination with flexible sigmoidoscopy (20% ). 
6. Discussion 
In this study we found that a computer-based CRC 
decision aid increased patient interest in screening and 
subjectively improved their knowledge about screening. 
Participants responded that they were more likely to ask their 
providers about screening after viewing the decision aid. These 
results are comparable to those from the videotape decision aid 
trial where patients' intent to ask providers for screening 
increased significantly after viewing the decision aid. In our 
current study, the computer-based decision aid also subjectively 
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improved patients' knowledge about screening and was useful to 
most in making decisions about whether to be screened. Other 
studies have also found that CRC decision aids increased 
patients' level of knowledge about screening; the videotape- and 
print-based versions developed by Meade eta!. improved patient 
knowledge about screening as determined by a change in score 
from expert-validated pre- and post-tests. 55 Dolan et a!. found 
that patients subjectively reported improved knowledge after 
using a CRC decision aid. 56 Improved knowledge is thought to 
lead to increased patient participation in medical decision 
making by empowering patients to make informed decisions with 
their provider. Incorporating patient values in the decision 
making process can potentially lead to the ordering oftests based 
on patient preferences. Although it is thought that patient 
involvement in medical decisions may lead to increased patient 
compliance with recommendations, 59• 60 there is no research to 
date that links shared decision making to increased patient 
compliance with screening tests. Future studies should be done to 
assess whether there is an association between shared decision 
making, test ordering based on patient preferences, and patient t 
compliance with screening. 
Our decision aid differs from previously developed 
versions for CRC screening in that, after viewing an overview 
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about screening, patients were able to interact with the aid via its 
computer-based format and choose to view additional segments 
on individual screening tests. In this way, patients could tailor 
the decision aid to meet their knowledge needs. Message 
tailoring is thought to stimulate cognitive activity, improve the 
relevance of the information presented, and make the message 
more effective, thus leading to a greater likelihood of behavior 
change.61 • 62 Tailored interventions have been used to increase 
other health promoting behaviors such as mammography 
screening. 63 The decision aid was not truly tailored in the sense 
that the information in the decision aid was not targeted towards 
individual patients' stage of readiness to be screened. Each 
patient, however, was able to select the amount and content of 
information they received about screening through the choices 
offered in the computer-based decision aid. In this way, the 
message about CRC and the importance of screening may have 
achieved greater relevance to patients and increased their interest 
and completion of screening. 
When asked about stage of readiness to be screened, most 
patients responded that they were ready to be screened after 
viewing the decision aid; of these patients, only about half had a 
test ordered and 43% completed a screening test. These results 
indicate that not all patients who want screening are having tests 
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ordered, but that most patients who had tests ordered completed 
their tests. There are a number of possible reasons for the low 
rates of test ordering. One possibility is that our intervention was 
patient-directed and did not have a system for prompting 
providers about screening. Although patients may have indicated 
an interest in screening, providers may not have discussed or 
ordered CRC screening tests during the patient encounter. 
Another reason for the low rates of test ordering is that some 
patients may have viewed the decision aid after seeing their 
provider and thus did not have the opportunity to discuss 
screening at that visit. Patients who were already up to date with 
screening prior to viewing the decision aid may not have had 
tests ordered even if they responded that they were ready for 
screening. Excluding these patients from the analysis, however, 
did not increase the proportion of tests ordered and completed 
among patients who were ready to be screened. 
The proportion of tests ordered and completed for 
patients who answered green (ready for screening) was higher 
than for patients who answered yellow or red (need more 
information or not ready for screening), but the differences were 
not statistically significant. There were small numbers of patients 
in our sample and there may not have been enough power to 
detect a significant difference between the groups. It is 
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interesting that approximately 40% of patients choosing yellow 
or red had tests ordered and one-third completed screening tests. 
It may be that these patients and providers had subsequent 
conversations about screening that led to test ordering or that 
some providers ordered tests without knowing patients' 
preferences for being screened. In the videotape decision aid 
study, only 7% of patients choosing red had tests ordered, and 
4% completed tests. More research needs to be done to determine 
why patients who were uncertain or not ready for screening had 
tests ordered and completed. j 
In order to achieve higher screening rates among those I ready to be tested, the decision aid may need to be implemented 
with a provider reminder system or standing orders for screening 
tests. A patient-oriented decision aid alone may be insufficient to 
increase test ordering and completion. Multifaceted interventions 
that target a combination of providers, patients, or office systems 
may be more likely to increase screening rates. 64 Dolan et al. 's 
patient-oriented decision aid was implemented without additional 
office systems or physician interventions. In their study there 
was no increase in CRC screening test completion among 
patients who viewed the decision aid vs. controls. 56 Our 
previously developed videotape decision aid included a provider 
notification component; the videotape was paired with a color-
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coded chart marker that notified providers about patients' 
readiness to be screened. The combination of the decision aid 
and chart marker resulted in a statistically significant increase in 
the percentage of tests ordered and completed in the intervention 
group vs. controls. 57 Physician prompting has been shown to 
increase performance of preventive care, including cancer 
screening, 65• 66 and may be a necessary component in a screening 
program to ensure that physicians order recommended tests. In a 
standing orders protocol, test ordering can be initiated by a nurse f 
; 
based on patient preferences and a previously developed 
screening policy agreed upon by providers in the practice. If the 
patient or provider later decide against screening, the order can 
be cancelled. Implementing the computer-based decision aid 
with a standing orders protocol or a provider prompting system 
may help to improve rates of screening test ordering. f 
+ 
Among the 47 patients who were ready to be screened, 
most rated the ability to find cancer as the most important factor 
in deciding on a screening test, and 42% chose colonoscopy as 
their preferred method for screening. Those patients who value 
accuracy may be more likely to choose colonoscopy for its 
ability to detect and remove neoplasms. Previous studies on 
patient preferences for colorectal cancer screening have also 
found that patients rank accuracy as the most important feature 
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of a screening test. Ling et al. found that 54% of patients 
considered accuracy to be the most important factor in selecting 
a screening method. 46 Among those who most valued accuracy, 
colonoscopy was the preferred method of screening. 
Interestingly, this study also found that providers viewed 
discomfort as the most important factor for patients when 
deciding about screening. Accuracy appears to be a very 
important factor for many patients in screening and should be 
considered by providers when discussing test options with 
patients. 
There are a number oflimitations to this trial. First, it was 
an uncontrolled trial without a comparison group, so it is unclear 
whether the proportion of patients having tests ordered and 
completed represents an increase compared to patients who did 
not view the decision aid. The baseline rates of CRC screening 
test ordering and completion in our clinic are not known and it is 
uncertain whether our results represent an increase over baseline 
clinic CRC screening rates for average-risk adults 50 and older. 
Although clinic screening rates are unknown, our results appear 
to be fairly comparable with those from the videotape decision 
aid trial; among patients viewing the videotape decision aid, 4 7% 
of individuals had screening ordered, and 37% completed tests. It 
may be useful to conduct a randomized trial comparing the 
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decision aid to a control group to see if viewing the decision aid 
can increase the rates of screening test ordering and completion. 
Another limitation is possible selection bias; the 
responses of those who chose to participate may be different 
from those who did not participate. The fact that some of the 
patients were referred by providers may have resulted in an 
increase in the proportion of patients who were ready to be 
screened and may have elevated rates of test ordering and 
completion. Our results also may have been biased by the fact 
that many participants had previously been screened; 48% had 
been previously screened for CRC and 19% were up to date with 
screening. Patients who have previously been screened may have 
been more ready for screening than those who had never been 
tested. In addition, those who were already up to date with 
screening may have been less likely to have tests ordered, 
although excluding these patients from the analysis did not 
change the proportion of patients having tests ordered or 
completed. 
Because our study was conducted at a single site among a 
clinic population, our study findings may not be generalizable to 
other populations. Other patient populations, including 
individuals not currently enrolled in medical care, might respond 
differently to the decision aid. In addition, patients in our sample 
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had high levels of education and most had health insurance. 
Although Medicare covers CRC screening and added 
colonoscopy to its list of covered services in 2001,35 cost is still 
an issue for patients without insurance or those whose plans may 
not cover CRC screening. Testing of the decision aid in 
population-based samples will provide information on whether 
the decision aid is useful to patients of varying levels of 
education and insurance status. 
A final limitation is that the decision aid may be difficult 
to use for those unfamiliar with computers. Patients who are have 
limited computer skills may find it hard to navigate through the 
menu of choices in the decision aid. Such patients may not be 
able to view the decision aid without assistance. Most patients in 
this study completed the decision aid successfully and required 
limited, if any, computer assistance, so computer literacy may be 
an issue for only a subset of patients. 
7. Conclusions and Implications 
Despite these limitations, our computer-based decision 
aid increased patient interest in screening, improved self-rated 
knowledge about screening, and was useful to patients in 
deciding whether to be screened. It is interactive, easy to use, and 
takes approximately 20 minutes of patient time. Most patients 
could independently navigate through the menu of choices to 
select video segments that met their knowledge needs. 
There are many ways in which the decision aid can be 
incorporated into primary care practice. Patients can view the 
decision aid in preparation for a visit with their provider. 
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Because the decision aid explains the importance of CRC 
screening and describes each screening test with its risks and 
benefits, the decision aid can potentially save providers time in 
counseling patients about screening. Its web-based format can be 
made accessible to patients and can be viewed by patients via 
their home computers. prior to their appointments. Nurses can 
identify patients at triage who are due for CRC screening, and 
these patients can view the decision aid in the office while 
waiting to see their provider. The computer-based format allows 
for modifications ifthere are changes in screening 
recommendations or new research findings about screening tests. 
It can also be translated into different languages to reach non-
English speaking patients; a Spanish language version is 
currently under development. This translated version will allow 
for dissemination of the aid to Spanish-speaking patients and will 
help inform their decisions about CRC screening. 
In this study, a computer-based, patient-directed decision 
aid increased patient interest in colorectal cancer screening and 
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subjectively improved knowledge about screening options. Most 
patients were ready to be screened after viewing the decision aid 
but only half of the patients who wanted to be screened had tests 
ordered. Future research needs to be done to determine whether 
implementation of the decision aid with other interventions such 
as provider reminders or a standing order system can effectively 
raise screening rates in a primary care setting. 
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Table 1: Colorectal Cancer Screening Guidelines for Average 
Risk Individuals 50 years and older*1•21-23• 67 
Any one of the following: 
I. Yearly fecal occult blood testing (FOBT) 
2. Flexible sigmoidoscopy (FS) every 5 years 
3. Combined yearly FOBT and FS every 5 years** 
4. Colonoscopy every 10 years 
5. Double-contrast barium enema every 5 years 
*Recommendations of the American Gastroenterological 
Association Consortium Panel, US Preventive Services Task 
Force, American Cancer Society (ACS) 
** ACS recommends the combination ofFS and FOBT over 
either test alone 
Table 2. Characteristics of the sample (n=SO). 
Characteristic Mean (range) or 
percent 
Mean age 60 (49-75) 
%Male 59 
%White 69 
% African American 29 
%Insured 81 
% More than high school 65 
education 
% Self-rated excellent-good 67 
health 
% Screened for colorectal 48 
cancer in the past 
%Up to date with screening 19 
l 
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Figure 1. Change in intent to be screened after viewing the 
decision aid 
4 
3.5 
3 
2.5 
2 
1.5 
1 
50 
Interest in Screening in Intent to ask Provider 
next 6 mos* about screening** 
* p=0.01, paired t-test. Based on 4-point Likert scale, 1 =not at all 
interested, 4=very interested 
** p<O.OOO 1, paired t-test. Based on 4-point Likert scale, 1 =not at all 
likely to ask, 4=very likely to ask 
Table 3. 3-6 month follow-up: Screening test ordering and 
completion (n=80) 
Colonoscopy/ 
Total FOBT sigmoidoscopy 
%Ordered 46 25 25 
%Completed 39 16 24 
Table 4. Test ordering and completion by stage of readiness 
to be screened 
msefore 
Decision 
Aid 
Ill After 
Decision 
Aid 
' r
I 
" 
Stage of n %ordering 
Readiness test* 
Green: ready to 
be tested 47 
Yellow: need 
more 18 
Information 
Red: not ready for 
screemng 15 
*p=0.59, Pearson s cht-square test 
**p=0.71, Pearson's chi-square test 
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